Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,293.00p

Buy

1,295.00p

arrow-up21.00p (+1.63%)

Prices updated at 02 Apr 2026, 17:20 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
FTSE All-Share
arrow-up0.59%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Mazen Samih Taleb Darwazah
CEO
Mr. Said Darwazah
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
9,603
Head office
1 New Burlington Place
London
United Kingdom
W1S 2HR
mobile
+44 2073992760
letter
uk-investors@hikma.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Douglas Michael Hurt
Non-Executive Director, Senior Independent Director
-
Ms. Victoria Mary Hull
Non-Executive Director, Chairman
-
Mr. Mohammed Ali Khaldoun S Al-Husry
Non-Executive Director
-
Ms. Cynthia L. Flowers
Non-Executive Director
-
Dr. Deneen Vojta, M.D.
Non-Executive Director
-
Ms. Laura Balan
Non-Executive Director
-
Mr. Mazen Samih Taleb Darwazah
Executive Director, Vice Chairman
-
Mr. Said Darwazah
Executive Director, Chief Executive Officer
-
Mr. Khalid Walid Hussni Nabilsi
Executive Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Boston Partners5,005,009
Boston Partners International Equity4,559,054
John Hancock Investment Management LLC4,494,670
JHancock Disciplined Value Intl Fd4,466,863
Jupiter Unit Trust Managers Ltd4,398,673

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
19 Dec 2025Purchase
07 Nov 2025Purchase
07 Nov 2025Purchase
07 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
22 Sep 2025D
16 Sep 2025Purchase
22 Aug 2025Purchase
07 Aug 2025Purchase
30 May 2025Transfer in
30 May 2025Transfer in
30 May 2025Sale
30 May 2025Transfer in
06 May 2025D
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.